Real-World experience of interictal burden and treatment in migraine: a qualitative interview study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1129-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Real-World experience of interictal burden and treatment in migraine: a qualitative interview study ; volume:23 ; number:1 ; day:8 ; month:6 ; year:2022 ; pages:1-10 ; date:12.2022
The journal of headache and pain ; 23, Heft 1 (8.6.2022), 1-10, 12.2022
- Creator
-
Lo, Siu Hing
Gallop, Katy
Smith, Timothy
Powell, Lauren
Johnston, Karissa
Hubig, Lena T.
Williams, Emma
Coric, Vladimir
Harris, Linda
L’Italien, Gilbert
Lloyd, Andrew J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s10194-022-01429-5
- URN
-
urn:nbn:de:101:1-2022080519315681879364
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lo, Siu Hing
- Gallop, Katy
- Smith, Timothy
- Powell, Lauren
- Johnston, Karissa
- Hubig, Lena T.
- Williams, Emma
- Coric, Vladimir
- Harris, Linda
- L’Italien, Gilbert
- Lloyd, Andrew J.
- SpringerLink (Online service)
Other Objects (12)
Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience
Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
Impact of a reimbursement policy change on treatment with erenumab in migraine – a real-world experience from Germany
Real-World Heart Failure Burden in Thai Patients
Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience
Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study
Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy© Application
A prospective real-world analysis of erenumab in refractory chronic migraine
A Prospective Real-World Study Exploring Associations Between Passively Collected Tracker Data and Headache Burden Among Individuals with Tension-Type Headache and Migraine
Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience
Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
Impact of a reimbursement policy change on treatment with erenumab in migraine – a real-world experience from Germany
Real-World Heart Failure Burden in Thai Patients
Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience
Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study
Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy© Application
A prospective real-world analysis of erenumab in refractory chronic migraine
A Prospective Real-World Study Exploring Associations Between Passively Collected Tracker Data and Headache Burden Among Individuals with Tension-Type Headache and Migraine
Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience
Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
Impact of a reimbursement policy change on treatment with erenumab in migraine – a real-world experience from Germany
Real-World Heart Failure Burden in Thai Patients
Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience
Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study
Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy© Application
A prospective real-world analysis of erenumab in refractory chronic migraine